We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 712

2017 Telemedicine and Digital Health Survey
  • Foley & Lardner LLP
  • USA
  • November 15 2017

Fueled by surging demand among patients and providers, telemedicine is spreading rapidly throughout the health care system, according to the 2017

California Passes Drug Transparency Law with Onerous Reporting Requirements for Manufacturers
  • Arent Fox LLP
  • USA
  • October 20 2017

Following in the steps of Maryland and Nevada, California just adopted a comprehensive drug pricing transparency law that will have a significant

CNN Investigates Expanding Use of Nuedexta in Nursing Homes
  • Stark & Stark
  • USA
  • October 16 2017

A recent investigation by CNN brought to light the expanding and allegedly inappropriate use of the prescription drug Nuedexta in nursing homes

America’s Opioid Epidemic: Who Will Be Held Accountable?
  • Husch Blackwell LLP
  • USA
  • October 11 2017

In recent years America has seen an increasing number of opioid-involved deaths and is currently experiencing what the Center for Disease Control

Ohio Attorney General Sues Pharmaceutical Companies Over Opioid Marketing - Yet Another Sign of Government Focus on Recovering Financial Cost of Opioid Epidemic
  • Pietragallo Gordon Alfano Bosick & Raspanti LLP
  • USA
  • June 9 2017

Last week, Ohio Attorney General Mike DeWine filed a lawsuit against multiple pharmaceutical companies, including Purdue, Teva, Johnson & Johnson

New FDA Commissioner Hits the Ground Running
  • Foley & Lardner LLP
  • USA
  • May 30 2017

Fresh off his noticeably smooth confirmation, the new Commissioner of Food and Drugs, Dr. Scott Gottlieb, appeared before Congress last Thursday and

Capitol Hill Healthcare Update
  • Baker & Hostetler LLP
  • USA
  • May 19 2017

Legislation reauthorizing FDA user fees for prescription and generic drugs, biosimilars, and medical devices won wide bipartisan approval last week in

Health Law Update - May 18, 2017
  • Baker & Hostetler LLP
  • USA
  • May 18 2017

Welcome to this week's edition of the Health Law Update. In this Issue Capitol Hill Healthcare Update Senate Panel OKs FDA User Fees Legislation

Third Circuit joins other circuits in enforcing Escobar's strict materiality requirement
  • DLA Piper
  • USA
  • May 4 2017

The Third Circuit has affirmed the district court's dismissal of a relator's claims in United States ex rel. Petratos, et al. V. Genentech Inc, et al

California Compounding Pharmacy Faces Civil Suit over Failure to Warn Consumer Regarding Dangers of Testosterone Cream
  • FisherBroyles LLP
  • USA
  • April 25 2017

Great Earth Compounding Pharmacy, along with a pharmacist, integrative medicine center, and two doctors, all based in southern California, are being